Entelexo Biotherapeutics
entelexo.com
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Registers and programsofficial lists and records that name the company
| Legal entity | Entelexo Biotherapeutics Inc. | SEC Form D |
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Developing a novel class of cancer therapeutics for solid tumors.
Our modular engineering platform allows us to create optimized Tregs phenotypes tailored to address a wide variety of autoimmune…
星锐医药(Starna Therapeutics) 成立于2021年8月，公司聚焦肝外靶向递送技术，致力于研发以RNA为核心的创新药物，解决未被满足的临床需求。核心团队来自知名药企、高校和研究院所，团队拥有深厚的核酸药物发现、递送技术和制剂开发能力。.
Mercury Biosciences presents a benchtop, hands-off, extracellular vesicle isolation system that directly processes any bodily fluid and…
Manage Consent To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to…
Logic gated immunotherapies for cancer and autoimmune disease. Synolo Therapeutics is advancing a new class of therapeutics for cancer.
Overview
Novel methods of engineeringtherapeutic exosomes. Our proprietary engineering platform allows us to develop a new class of exosome-based therapeutics.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Irvine
United States
HQ